| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
GeneOne Life Science Inc (KO: 011000)
011000 Technical Analysis
5
| As on 14th Jan 2025 011000 STOCK Price closed @ 2450.00 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 6229.24 & Strong Sell for SHORT-TERM with Stoploss of 12829.22 we also expect STOCK to react on Following IMPORTANT LEVELS. |
011000STOCK Price
| Open | 2540.00 | Change | Price | % |
| High | 2560.00 | 1 Day | -65.00 | -2.58 |
| Low | 2420.00 | 1 Week | 250.00 | 11.36 |
| Close | 2450.00 | 1 Month | 225.00 | 10.11 |
| Volume | 703458 | 1 Year | -13437.82 | -84.58 |
| 52 Week High 17683.00 | 52 Week Low 1938.00 | ||||
KO Korea Most Active Stocks
| 096300 | 156.00 | -6.02% |
| 096300 | 156.00 | -6.02% |
| 168490 | 159.00 | 29.27% |
| 168490 | 159.00 | 29.27% |
| 006340 | 3890.00 | -2.51% |
| 006340 | 3890.00 | -2.51% |
| 001380 | 3635.00 | 8.83% |
| 001380 | 3635.00 | 8.83% |
| 005930 | 53900.00 | -0.37% |
| 014160 | 1360.00 | 2.18% |
KO Korea Top Gainers Stocks
KO Korea Top Losers Stocks
| 011000 Daily Charts |
011000 Intraday Charts |
Whats New @ Bazaartrend |
011000 Free Analysis |
|
|
011000 Important Levels Intraday
| RESISTANCE | 2719.78 |
| RESISTANCE | 2633.26 |
| RESISTANCE | 2579.78 |
| RESISTANCE | 2526.30 |
| SUPPORT | 2373.70 |
| SUPPORT | 2320.22 |
| SUPPORT | 2266.74 |
| SUPPORT | 2180.22 |
011000 Forecast January 2025
| 4th UP Forecast | 16708.4 |
| 3rd UP Forecast | 12135.6 |
| 2nd UP Forecast | 9309.12 |
| 1st UP Forecast | 6482.6 |
| 1st DOWN Forecast | -1582.6 |
| 2nd DOWN Forecast | -4409.12 |
| 3rd DOWN Forecast | -7235.64 |
| 4th DOWN Forecast | -11808.4 |
011000 Weekly Forecast
| 4th UP Forecast | 11322.64 |
| 3rd UP Forecast | 8477.13 |
| 2nd UP Forecast | 6718.26 |
| 1st UP Forecast | 4959.39 |
| 1st DOWN Forecast | -59.39 |
| 2nd DOWN Forecast | -1818.26 |
| 3rd DOWN Forecast | -3577.13 |
| 4th DOWN Forecast | -6422.64 |
011000 Forecast2025
| 4th UP Forecast | 37732.7 |
| 3rd UP Forecast | 26417.3 |
| 2nd UP Forecast | 19423 |
| 1st UP Forecast | 12428.8 |
| 1st DOWN Forecast | -7528.75 |
| 2nd DOWN Forecast | -14523 |
| 3rd DOWN Forecast | -21517.3 |
| 4th DOWN Forecast | -32832.7 |
GeneOne Life Science Inc ( KO Korea Symbol : 011000 )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
011000 Business Profile
GeneOne Life Science, Inc., a biopharmaceutical company, engages in the development and contract manufacturing of gene-based-biomedicines. Its products comprise GLS-1027, which is in Phase I clinical trial for treatment of nephropathy and inflammatory diseases; GLS-1200 that is in Phase II clinical trial to treat Rhinosinusitis; GLS-1027 and GLS-1200, which is Phase II clinical trial for treatment of COVID-19. The company also develops GLS-3000 and GLS-5310 for the treatment of SARS-CoV-2; GLS-5100 to treat VZV-Shingles; and GLS-5140 for the treatment of SFTS. In addition, it is developing GLS-5300, which is in Phase II clinical trial for MERS; GLS-5700 that is in Phase I clinical trial for Zika; and GLS-6150, which is in Phase I clinical trial for treatment of hepatitis C, as well as GLS-6100 that is in pre-clinical stage for hepatitis C. Further, the company, through its subsidiary, VGXI, Inc., engages in the cGMP production of nucleic acid-based products, including DNA plasmids and mRNA. The company was formerly known as VGX International Inc. and changed its name to GeneOne Life Science, Inc. in April 2014. GeneOne Life Science, Inc. was founded in 1976 and is headquartered in Seoul, South Korea. Address: The Pinnacle Gangnam, Seoul, South Korea, 06060
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service